Table 3 Primary and major secondary endpoints for glucose and insulin
GI Labs (n = 40) | RCFFN (n = 40) | |||
---|---|---|---|---|
CR | ONO | CRsns | ONOsns | |
Glucose | ||||
iAUC0–2 (mmol × min/l) | 117.2 ± 49.5 | 78.3 ± 41.8* | 178.9 ± 71.4† | 135.9 ± 60.4†* |
iAUC2–3 (mmol × min/l) | 1.7 ± 3.6 | 5.4 ± 7.4* | 7.6 ± 9.7* | 12.1 ± 15.3* |
iAUC0–3 (mmol × min/l) | 118.9 ± 49.6 | 83.7 ± 44.4* | 186.5 ± 75.2† | 148.0 ± 67.2†* |
Peak rise (mmol/l) | 2.97 ± 0.80 | 1.87 ± 0.60* | 3.72 ± 0.89† | 2.72 ± 0.87†* |
Fasting (mmol/l) | 4.62 ± 0.40 | 4.62 ± 0.42 | 5.18 ± 0.51 | 5.17 ± 0.48 |
2 h (mmol/l) | 4.41 ± 0.45‡ | 4.67 ± 0.40* | 5.31 ± 0.80 | 5.44 ± 0.54‡ |
2 h increment (mmol/l) | −0.21 ± 0.42 | 0.05 ± 0.36* | 0.13 ± 0.68† | 0.27 ± 0.65‡ |
Above:below fasting at 2 h | 13:27 | 22:18a | 22:18b | 26:14 |
Insulin | ||||
iAUC0–2 (pmol × h/l) | 174.6 ± 120.7 | 117.6 ± 90.1* | 302.3 ± 175.3† | 205.7 ± 113.9†* |
iAUC2–3 (pmol × h/l) | 4.2 ± 7.3 | 8.1 ± 11.8 | 22.7 ± 32.8* | 19.2 ± 21.6* |
iAUC0–3 (pmol × h/l) | 178.7 ± 123.0 | 125.7 ± 92.4* | 325.0 ± 196.9† | 225.9 ± 129.8†* |
Peak rise (pmol/l) | 278 ± 197 | 185 ± 146* | 367 ± 180†* | 250 ± 139† |